DOI: 10.4244/EIJV7I1A4

Patrick W. Serruys and the roots of PCR

Jean Marco1*, MD; Marc Doncieux2

Jean Marco

The first time I met Patrick Serruys was at a meeting organised by Paul G. Hugenholtz, one of the founders of the ESC and Emeritus Professor of Cardiology at the Erasmus Medical Centre, Rotterdam. Iremember some slight divergence of opinion on the treatment of myocardial infarction –specifically on the place of fibrinolysis as compared to PTCA– and I was immediately struck by how Patrick went right to the core of what was essential, arguing that it was important to completely analyse one strategy and finding a consensus on that strategy, rather than having multiple approaches. The next time we came together was in Toulouse at the first meeting on angioplasty and revascularisation in January of 1983. Patrick Serruys was relatively unknown at the time –hard to imagine today– but his visionary lecture on “Computerised quantitative coronary angiography (QCA) applied to PTCA” was so clear and inspiring that several of the participants approached me asking who this brilliant speaker was, saying that they were struck by his “intelligence and brio”.

At the end of these early courses there was a discussion with worldwide experts about the use of guidewires and the place of guidewires in our daily work. John Simpson presented his first experience with the steerable wire technique. The conclusion was that 15%, maybe 20%, of our interventions would use them! Patrick –who always had an encompassing approach, a global vision of the future that guided his thinking– told me that “after 20 years we will probably completely forget all these initial conclusions.”

At the very beginning of PCR history, at the “Complex coronary angioplasty and new techniques in interventional cardiology Course” organised in Toulouse in 1989, Patrick naturally took his place as one our key, privileged speakers and participants in the course. This is a part he plays so well, and his role has only grown in importance as the course evolved. When later he created EURO CVS in Rotterdam, his goal was, like ours, to further the essential reflections and practice in our discipline, there was never any competition between our two groups.

From our earliest collaborations Patrick Serruys was involved in the printed material generated by EuroPCR, and was instrumental in the book we published at one of the early courses, a book which in a very real way acted as a scientific anchor to the practical aspects of the course. His engagement in this ongoing reflection our knowledge and experience and its effective diffusion has always been paramount to him. Concerning EuroIntervention and the various supplements and books that we are working on, his presence has always been actively felt on every level, from the creation of the journal itself to, of course, its content.

What has remained constant for me about Patrick Serruys throughout all these years is the way he brings his unique intelligence to all he touches; always with a sly sense of humour and an enormous scientific and quantitative rigour. Patrick has always maintained afresh and creative analysis of scientific content, and this –fused with the practical aspects of PCR itself– advances our discipline and defines what we are trying to accomplish in interventional medicine and education.

Today he is, without doubt, one of our most brilliant thinkers, perhaps in the history of European interventional cardiology. As both ascientist and clinician, Patrick Serruys is the clear leader of our generation in the creation and conduct of studies, research and in the reporting of data. And he does this always with a certain grace, never losing the incredible scientific and human dimension of his presence and work.

Marc Doncieux

The PCR family was born out of the evolution in knowledge, practice and technique that owes much to the dedication of its founders. Its early roots can be traced to a series of encounters between Jean Marco and Patrick Serruys in the late 70s and early 80s which played a key role in its development. EuroPCR directly –and the entire PCR family indirectly– was born out of, and in a sense came of age, through the evolution in the interaction between Patrick Serruys and Jean Marco. This is an interaction that I have had the honour of witnessing, and in my own way, supporting. The force of Patrick in the history EuroPCR and the PCR family has always been his incredible vision, what he sees, his power of analysis, his ability to bring these ideas and concepts together, his ability to synthesise.

He looks towards the future... and PCR has always benefited from his vision.

From my point-of-view, managing the non-medical aspects of PCR, what struck me was the consistency in which he treated us all, and the interest he took in all the parts of our work, not only the clinical aspects of interventional cardiology, but the transmission of that knowledge through the course and other forms of communications. His constant attention and commitment to such things as the course book that Jean Marco mentioned earlier, formed the initial nucleus of what would become EuroIntervention and PCR publishing. His attention to detail and love of innovation –when innovation can really work– has led to our current creation of web and electronic based media, as well as the enormous challenges of the upcoming textbook.

Throughout all these years I have been most struck by the strong spirit of collaboration rather than competition that has characterised Patrick Serruys’s relationship to us. From the beginning, Iremember the mutual respect and admiration that existed between Jean Marco and Patrick, a respect that continues to this day. By 1999, when the two courses joined together, there was a true symbiosis, aquality that has allowed for the progressive development of not only EuroPCR and the entire PCR family, but, more importantly for the lively promulgation of knowledge in the field of interventional cardiology.

Through Patrick, we have been given the chance to have a strong European presence in an international arena, and the Lifetime Achievement award that Patrick Serruys received from the American College of Cardiology is further testimony that the esteem we hold him in here in Toulouse and throughout Europe is clearly echoed by the international community as well.

Volume 7 Number 1
May 17, 2011
Volume 7 Number 1
View full issue


Key metrics

Suggested by Cory

May 17, 2011
Patrick W. Serruys and the EAPCI
Di Mario C
free

10.4244/EIJV7I1A5 May 17, 2011
Patrick Washington Serruys: a view from across the Atlantic
King S
free

10.4244/EIJV13I1A1 May 15, 2017
What is it to become an octogenarian 40 years after the first angioplasty?
Serruys PW and Onuma Y
free

10.4244/EIJV15I15A235 Feb 7, 2020
EuroIntervention: moving forward
Capodanno D
free

10.4244/EIJV13I1A5 May 15, 2017
Marking an anniversary: interventional cardiology at 40
Haude M
free

10.4244/EIJV12I17A335 Apr 20, 2017
40 years of angioplasty – remembering patients and pioneers
Byrne RA
free

10.4244/EIJV12I8A154 Oct 10, 2016
Paul Cummins, Managing Editor: farewell and many thanks!
Serruys PW
free

10.4244/EIJ-E-21-00004 Jan 28, 2022
EuroIntervention: the 200th issue
Serruys PW
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved